Multicenter clinical trial of pioitazone in type 2 diabetes: impact on expression of soluble receptor for advanced glycation end-products (PioRAGE).
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Dec 2010
At a glance
- Drugs Glimepiride (Primary) ; Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms PioRAGE
- 09 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 14 Jun 2009 New trial record